Aadi Bioscience, Inc.

Good day, and thank you for standing by. Welcome to the Addy Bioscience, Inc. Second Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 11 on your telephone. Please be advised that today's conference is being recorded. I would now like to hand the conference over to Marcy Graham, Senior Vice President of Investor Relations and Corporate Communications at Addi Bioscience. Ms.

Graham, please go ahead. Thank you.

Good morning, and welcome to the ADDIE Bioscience Conference Call to review results of and provide an update on the second quarter of 2022. Joining me on the call today is our President and CEO, Neil Desai, who will provide an overview of the quarter, followed by our Chief Operating Officer, Brendan Delaney, who will give us an update on our early commercial progress. Next will be our Chief Medical Officer, Dr. Loretta Etrie, who will give us a brief update on our clinical progress. followed by our CFO, Scott Giacobbello, with review of our financial performance during the period. We will close with some final thoughts from Neil and then open the line for questions. Before we get started, a quick reminder that statements made on the call today will include forward-looking statements. Actual events or results could differ materially from those expressed or implied by any forward-looking statement as a result of various risks, uncertainties, or other factors. including those set forth in the risk factors section of our annual and quarterly filings with the Security and Exchange Commission, which can be found at www.sbc.gov or on our website at www.addibio.com. In addition, any forward-looking statements made on this call represent our views only as of today, August 10th, 2022, and should not be relied upon as representing our views as of any subsequent date. We specifically disclaim any obligation to update or revise any forward-looking statements. With that, I will turn the call over to Neal for his opening statements. Neal?